Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data

Pauline Vabre, Nicolas Gatimel, Jessika Moreau, Véronique Gayrard, Nicole Picard-Hagen, Jean Parinaud, Roger D Leandri, Pauline Vabre, Nicolas Gatimel, Jessika Moreau, Véronique Gayrard, Nicole Picard-Hagen, Jean Parinaud, Roger D Leandri

Abstract

Background: Because only 25% of cases of premature ovarian insufficiency (POI) have a known etiology, the aim of this review was to summarize the associations and mechanisms of the impact of the environment on this pathology. Eligible studies were selected from an electronic literature search from the PUBMED database from January 2000 to February 2016 and associated references in published studies. Search terms included ovary, follicle, oocyte, endocrine disruptor, environmental exposure, occupational exposure, environmental contaminant, pesticide, polyaromatic hydrocarbon, polychlorinated biphenyl PCB, phenol, bisphenol, flame retardant, phthalate, dioxin, phytoestrogen, tobacco, smoke, cigarette, cosmetic, xenobiotic. The literature search was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We have included the human and animal studies corresponding to the terms and published in English. We have excluded articles that included results that did not concern ovarian pathology and those focused on ovarian cancer, polycystic ovary syndrome, endometriosis or precocious puberty. We have also excluded genetic, auto-immune or iatrogenic causes from our analysis. Finally, we have excluded animal data that does not concern mammals and studies based on results from in vitro culture. Data have been grouped according to the studied pollutants in order to synthetize their impact on follicular development and follicular atresia and the molecular pathways involved. Ninety-seven studies appeared to be eligible and were included in the present study, even though few directly address POI. Phthalates, bisphenol A, pesticides and tobacco were the most reported substances having a negative impact on ovarian function with an increased follicular depletion leading to an earlier age of menopause onset. These effects were found when exposure occured at different times throughout the lifetime from the prenatal to the adult period, possibly due to different mechanisms. The main mechanism seemed to be an increase in atresia of pre-antral follicles.

Conclusion: Environmental pollutants are probably a cause of POI. Health officials and the general public must be aware of this environmental effect in order to implement individual and global preventive actions.

Keywords: Environment; Fertility; Ovarian reserve; Pollutants; Premature ovarian insufficiency.

Figures

Fig. 1
Fig. 1
The different mechanisms inducing POI. Folliculogenesis (❶) begins after assembly (black arrows) of primordial follicles during second trimester of pregnancy. Activation of primordial follicles (green color) to enter the growth phase of folliculogenesis is continuous from third trimester of fetal life to menopause. This activation is driven by local factors and is independent of gonadotropins. Basal follicular growth (pink color) is driven by paracrine factors. From the early antral follicle stage, their growth depends on gonadotrophins to enter the final phase (orange color) up to ovulation. From the beginning, follicles undergo physiological atresia (blue lines around arrows), that participate to the decrease of the pool with years. Mechanisms leading to POI (symbolized by a final pale preovulatory follicle,): • decrease of the pool of primordial follicles (❺) either due to massive atresia (❺a) or default in assembly (❺b). • increase in follicular apoptosis concerning any other follicular stage (❷ and ❸). • increase of the activation (large green arrow) of the resting pool of primordial follicles (❹) resulting in its exhaustion. It is generally followed by increased atresia at following follicular stages (large blue arrow). • default in basal follicular growth leading to its arrest before the antral stages preventing ovulation while the pool of primordial follicles is normal (❻)
Fig. 2
Fig. 2
Flow chart of the selection of articles
Fig. 3
Fig. 3
The major ways used by environmental pollutants to induce defaults in folliculogenesis leading to POI. Environmental pollutants can act through several mechanisms. • actions as endocrine disruptors as ligands to nuclear estrogen receptors (ER, salmon arrows) and aryl hydrocarbon receptors (AhR, blue arrows). Once linked to AhR, they can bind to AhR nuclear translocator (ARNT) to interfere with xenobiotoc responsive elements (XRE) from promotors and affect gene expression, notably promoting pro-apoptotic genes and inhibiting anti-apopototic genes. • creation of an imbalance between oxydative defenses and oxydative stress favoring apoptosis at different follicular stages (green arrows). • Modification of epigenetic marks such as DNA methylation (●) or histones post-traductional modifications (▸, , ●) affecting the transcriptional state of chromatin and therefore gene expression. • binding to several membrane receptors suchs as membrane bound ER (mER) or receptor protein tyrosine kinases (RPTK) activating the PI3 Kinase pathway are suspected (grey dotted arrows)

References

    1. Buck Louis GM, Sundaram R, Schisterman EF, Sweeney AM, Lynch CD, Gore-Langton RE, et al. Persistent environmental pollutants and couple fecundity: the LIFE study. Environ Health Perspect. 2013;121:231–6.
    1. Gascon M, Vrijheid M, Nieuwenhuijsen MJ. The built environment and child health: an overview of current evidence. Curr Environ Health Rep. 2016;3(3):250–57.
    1. Haruty B, Friedman J, Hopp S, Daniels R, Pregler J. Reproductive health and the environment: Counseling patients about risks. Cleve Clin J Med. 2016;83:367–72. doi: 10.3949/ccjm.83a.14070.
    1. Le Cann P, Bonvallot N, Glorennec P, Deguen S, Goeury C, Le Bot B. Indoor environment and children’s health: recent developments in chemical, biological, physical and social aspects. Int J Hyg Environ Health. 2011;215:1–18. doi: 10.1016/j.ijheh.2011.07.008.
    1. Barnes SK, Ozanne SE. Pathways linking the early environment to long-term health and lifespan. Prog Biophys Mol Biol. 2011;106:323–36. doi: 10.1016/j.pbiomolbio.2010.12.005.
    1. Landrigan PJ, Miodovnik A. Children’s health and the environment: an overview. Mt Sinai J Med. 2011;78:1–10. doi: 10.1002/msj.20236.
    1. Eshre Guideline Group on Premature ovarian insufficiency. Webber L, Davies M, Anderson R, Bartlett J, Braat D, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31:926–937. doi: 10.1093/humrep/dew027.
    1. Depmann M, Eijkemans MJ, Broer SL, Scheffer GJ, van Rooij IA, Laven JS, et al. Does anti-Mullerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study. Hum Reprod. 2016;31:1579–87. doi: 10.1093/humrep/dew112.
    1. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;1:9. doi: 10.1186/1750-1172-1-9.
    1. Goswami D, Conway GS. Premature ovarian failure. Horm Res. 2007;68:196–202.
    1. Qin Y, Jiao X, Simpson JL, Chen ZJ. Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update. 2015;21:787–808. doi: 10.1093/humupd/dmv036.
    1. Iorio R, Castellucci A, Ventriglia G, Teoli F, Cellini V, Macchiarelli G, et al. Ovarian toxicity: from environmental exposure to chemotherapy. Curr Pharm Des. 2014;20:5388–97. doi: 10.2174/1381612820666140205145319.
    1. Dragojevic-Dikic S, Vasiljevic M, Nikolic B, Pazin V, Tasic L, Jurisic A, et al. Premature ovarian failure: immunological aspects and therapeutic strategies. Vojnosanit Pregl. 2013;70:1051–5. doi: 10.2298/VSP1311051D.
    1. Jin M, Yu Y, Huang H. An update on primary ovarian insufficiency. Sci China Life Sci. 2012;55:677–86. doi: 10.1007/s11427-012-4355-2.
    1. Santulli P, de Villardi D, Gayet V, Lafay Pillet MC, Marcellin L, Blanchet V, et al. Decreased ovarian reserve in HIV-infected women. AIDS. 2016;30:1083–8. doi: 10.1097/QAD.0000000000001025.
    1. Cramer DW, Welch WR, Cassells S, Scully RE. Mumps, menarche, menopause, and ovarian cancer. Am J Obstet Gynecol. 1983;147:1–6. doi: 10.1016/0002-9378(83)90073-X.
    1. Richardson MC, Guo M, Fauser BC, Macklon NS. Environmental and developmental origins of ovarian reserve. Hum Reprod Update. 2014;20:353–69. doi: 10.1093/humupd/dmt057.
    1. Craig ZR, Wang W, Flaws JA. Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling. Reproduction. 2011;142:633–646. doi: 10.1530/REP-11-0136.
    1. Revelli A, Pacchioni D, Cassoni P, Bussolati G, Massobrio M. In situ hybridization study of messenger RNA for estrogen receptor and immunohistochemical detection of estrogen and progesterone receptors in the human ovary. Gynecol Endocrinol. 1996;10:177–86. doi: 10.3109/09513599609027986.
    1. Fowler PA, Anderson RA, Saunders PT, Kinnell H, Mason JI, Evans DB, et al. Development of steroid signaling pathways during primordial follicle formation in the human fetal ovary. J Clin Endocrinol Metab. 2011;96:1754–62. doi: 10.1210/jc.2010-2618.
    1. Luderer U. Ovarian toxicity from reactive oxygen species. Vitam Horm. 2014;94:99–127. doi: 10.1016/B978-0-12-800095-3.00004-3.
    1. Tokmak A, Yildirim G, Sarikaya E, Cinar M, Bogdaycioglu N, Yilmaz FM, et al. Increased oxidative stress markers may be a promising indicator of risk for primary ovarian insufficiency: a cross-sectional case control study. Rev Bras Ginecol Obstet. 2015;37:411–6.
    1. Uzumcu M, Zama AM, Oruc E. Epigenetic mechanisms in the actions of endocrine-disrupting chemicals: gonadal effects and role in female reproduction. Reprod Domest Anim. 2012;47(Suppl 4):338–347. doi: 10.1111/j.1439-0531.2012.02096.x.
    1. Nilsson E, Larsen G, Manikkam M, Guerrero-Bosagna C, Savenkova MI, Skinner MK. Environmentally induced epigenetic transgenerational inheritance of ovarian disease. PLoS One. 2012;7:e36129. doi: 10.1371/journal.pone.0036129.
    1. Manikkam M, Guerrero-Bosagna C, Tracey R, Haque MM, Skinner MK. Transgenerational actions of environmental compounds on reproductive disease and identification of epigenetic biomarkers of ancestral exposures. PLoS One. 2012;7:e31901. doi: 10.1371/journal.pone.0031901.
    1. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1.
    1. Grindler NM, Allsworth JE, Macones GA, Kannan K, Roehl KA, Cooper AR. Persistent organic pollutants and early menopause in U.S. women. PLoS One. 2015;10:e0116057. doi: 10.1371/journal.pone.0116057.
    1. Beranger R, Hoffmann P, Christin-Maitre S, Bonneterre V. Occupational exposures to chemicals as a possible etiology in premature ovarian failure: a critical analysis of the literature. Reprod Toxicol. 2012;33:269–79. doi: 10.1016/j.reprotox.2012.01.002.
    1. Heudorf U, Mersch-Sundermann V, Angerer J. Phthalates: toxicology and exposure. Int J Hyg Environ Health. 2007;210:623–34. doi: 10.1016/j.ijheh.2007.07.011.
    1. Hannon PR, Flaws JA. The effects of phthalates on the ovary. Front Endocrinol. 2015;6:8. doi: 10.3389/fendo.2015.00008.
    1. Moyer B, Hixon ML. Reproductive effects in F1 adult females exposed in utero to moderate to high doses of mono-2-ethylhexylphthalate (MEHP) Reprod Toxicol. 2012;34:43–50. doi: 10.1016/j.reprotox.2012.02.006.
    1. Zhang XF, Zhang T, Han Z, Liu JC, Liu YP, Ma JY, et al. Transgenerational inheritance of ovarian development deficiency induced by maternal diethylhexyl phthalate exposure. Reprod Fertil Dev. 2015;27:1213–21. doi: 10.1071/RD14113.
    1. Li L, Zhang T, Qin XS, Ge W, Ma HG, Sun LL, et al. Exposure to diethylhexyl phthalate (DEHP) results in a heritable modification of imprint genes DNA methylation in mouse oocytes. Mol Biol Rep. 2014;41:1227–35. doi: 10.1007/s11033-013-2967-7.
    1. Niermann S, Rattan S, Brehm E, Flaws JA. Prenatal exposure to di-(2-ethylhexyl) phthalate (DEHP) affects reproductive outcomes in female mice. Reprod Toxicol. 2015;53:23–32. doi: 10.1016/j.reprotox.2015.02.013.
    1. Zhang XF, Zhang LJ, Li L, Feng YN, Chen B, Ma JM, et al. Diethylhexyl phthalate exposure impairs follicular development and affects oocyte maturation in the mouse. Environ Mol Mutagen. 2013;54:354–61. doi: 10.1002/em.21776.
    1. Li L, Liu JC, Lai FN, Liu HQ, Zhang XF, Dyce PW, et al. Di (2-ethylhexyl) phthalate exposure impairs growth of antral follicle in mice. PLoS One. 2016;11:e0148350. doi: 10.1371/journal.pone.0148350.
    1. Hannon PR, Niermann S, Flaws JA. Acute exposure to Di(2-eEthylhexyl) phthalate in adulthood causes adverse reproductive outcomes later in life and accelerates reproductive aging in female mice. Toxicol Sci. 2016;150:97–108. doi: 10.1093/toxsci/kfv317.
    1. Sen N, Liu X, Craig ZR. Short term exposure to di-n-butyl phthalate (DBP) disrupts ovarian function in young CD-1 mice. Reprod Toxicol. 2015;53:15–22. doi: 10.1016/j.reprotox.2015.02.012.
    1. Li N, Liu T, Zhou L, He J, Ye L. Di-(2-ethylhcxyl) phthalate reduces progesterone levels and induces apoptosis of ovarian granulosa cell in adult female ICR mice. Environ Toxicol Pharmacol. 2012;34:869–75. doi: 10.1016/j.etap.2012.08.013.
    1. Hannon PR, Peretz J, Flaws JA. Daily exposure to Di(2-ethylhexyl) phthalate alters estrous cyclicity and accelerates primordial follicle recruitment potentially via dysregulation of the phosphatidylinositol 3-kinase signaling pathway in adult mice. Biol Reprod. 2014;90:136. doi: 10.1095/biolreprod.114.119032.
    1. Xu C, Chen JA, Qiu Z, Zhao Q, Luo J, Yang L, et al. Ovotoxicity and PPAR-mediated aromatase downregulation in female Sprague-Dawley rats following combined oral exposure to benzo[a]pyrene and di-(2-ethylhexyl) phthalate. Toxicol Lett. 2010;199:323–32. doi: 10.1016/j.toxlet.2010.09.015.
    1. Messerlian C, Souter I, Gaskins AJ, Williams PL, Ford JB, Chiu YH, et al. Urinary phthalate metabolites and ovarian reserve among women seeking infertility care. Hum Reprod. 2016;31:75–83. doi: 10.1093/humrep/dev292.
    1. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect. 2005;113:391–5. doi: 10.1289/ehp.7534.
    1. Berger A, Ziv-Gal A, Cudiamat J, Wang W, Zhou C, Flaws JA. The effects of in utero bisphenol A exposure on the ovaries in multiple generations of mice. Reprod Toxicol. 2016;60:39–52. doi: 10.1016/j.reprotox.2015.12.004.
    1. Zhang HQ, Zhang XF, Zhang LJ, Chao HH, Pan B, Feng YM, et al. Fetal exposure to bisphenol A affects the primordial follicle formation by inhibiting the meiotic progression of oocytes. Mol Biol Rep. 2012;39:5651–7. doi: 10.1007/s11033-011-1372-3.
    1. Rodriguez HA, Santambrosio N, Santamaria CG, Munoz-de-Toro M, Luque EH. Neonatal exposure to bisphenol A reduces the pool of primordial follicles in the rat ovary. Reprod Toxicol. 2010;30:550–7. doi: 10.1016/j.reprotox.2010.07.008.
    1. Li Y, Zhang W, Liu J, Wang W, Li H, Zhu J, et al. Prepubertal bisphenol A exposure interferes with ovarian follicle development and its relevant gene expression. Reprod Toxicol. 2014;44:33–40. doi: 10.1016/j.reprotox.2013.09.002.
    1. Souter I, Smith KW, Dimitriadis I, Ehrlich S, Williams PL, Calafat AM, et al. The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments. Reprod Toxicol. 2013;42:224–31. doi: 10.1016/j.reprotox.2013.09.008.
    1. Caserta D, Di Segni N, Mallozzi M, Giovanale V, Mantovani A, Marci R, et al. Bisphenol A and the female reproductive tract: an overview of recent laboratory evidence and epidemiological studies. Reprod Biol Endocrinol. 2014;12:37. doi: 10.1186/1477-7827-12-37.
    1. Machtinger R, Orvieto R. Bisphenol A, oocyte maturation, implantation, and IVF outcome: review of animal and human data. Reprod Biomed Online. 2014;29:404–10. doi: 10.1016/j.rbmo.2014.06.013.
    1. Kotil T, Yon ND. The effects of permethrin on rat ovarian tissue morphology. Exp Toxicol Pathol. 2015;67:279–85. doi: 10.1016/j.etp.2015.01.005.
    1. Satar DA, Tap O, Ay MO. Electron microscopic examination of the effects of methyl parathion exposure on the ovaries. Eur Rev Med Pharmacol Sci. 2015;19:2725–31.
    1. Park S, Kim S, Jin H, Lee K, Bae J. Impaired development of female mouse offspring maternally exposed to simazine. Environ Toxicol Pharmacol. 2014;38:845–51. doi: 10.1016/j.etap.2014.10.008.
    1. El-Sharkawy EE, Kames AO, Sayed SM, Nisr NA, Wahba NM, Elsherif WM, et al. The ameliorative effect of propolis against methoxychlor induced ovarian toxicity in rat. Exp Toxicol Pathol. 2014;66:415–21. doi: 10.1016/j.etp.2014.06.003.
    1. Bhattacharya P, Keating AF. Impact of environmental exposures on ovarian function and role of xenobiotic metabolism during ovotoxicity. Toxicol Appl Pharmacol. 2012;261:227–35. doi: 10.1016/j.taap.2012.04.009.
    1. Craig ZR, Hannon PR, Flaws JA. Pregnenolone co-treatment partially restores steroidogenesis, but does not prevent growth inhibition and increased atresia in mouse ovarian antral follicles treated with mono-hydroxy methoxychlor. Toxicol Appl Pharmacol. 2013;272:780–6. doi: 10.1016/j.taap.2013.08.002.
    1. Zama AM, Uzumcu M. Fetal and neonatal exposure to the endocrine disruptor methoxychlor causes epigenetic alterations in adult ovarian genes. Endocrinology. 2009;150:4681–91. doi: 10.1210/en.2009-0499.
    1. Farr SL, Cai J, Savitz DA, Sandler DP, Hoppin JA, Cooper GS. Pesticide exposure and timing of menopause: the Agricultural Health Study. Am J Epidemiol. 2006;163:731–42. doi: 10.1093/aje/kwj099.
    1. Baligar PN, Kaliwal BB. Induction of gonadal toxicity to female rats after chronic exposure to mancozeb. Ind Health. 2001;39:235–43. doi: 10.2486/indhealth.39.235.
    1. Cooper GS, Savitz DA, Millikan R, Chiu Kit T. Organochlorine exposure and age at natural menopause. Epidemiology. 2002;13:729–33. doi: 10.1097/00001648-200211000-00021.
    1. Akkina J, Reif J, Keefe T, Bachand A. Age at natural menopause and exposure to organochlorine pesticides in Hispanic women. J Toxicol Environ Health A. 2004;67:1407–22. doi: 10.1080/15287390490483845.
    1. Camlin NJ, McLaughlin EA, Holt JE. Through the smoke: use of in vivo and in vitro cigarette smoking models to elucidate its effect on female fertility. Toxicol Appl Pharmacol. 2014;281:266–75. doi: 10.1016/j.taap.2014.10.010.
    1. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet. 2001;28:355–60. doi: 10.1038/ng575.
    1. Anderson RA, McIlwain L, Coutts S, Kinnell HL, Fowler PA, Childs AJ. Activation of the aryl hydrocarbon receptor by a component of cigarette smoke reduces germ cell proliferation in the human fetal ovary. Mol Hum Reprod. 2014;20:42–8. doi: 10.1093/molehr/gat059.
    1. Sobinoff AP, Beckett EL, Jarnicki AG, Sutherland JM, McCluskey A, Hansbro PM, et al. Scrambled and fried: cigarette smoke exposure causes antral follicle destruction and oocyte dysfunction through oxidative stress. Toxicol Appl Pharmacol. 2013;271:156–67. doi: 10.1016/j.taap.2013.05.009.
    1. Sun L, Tan L, Yang F, Luo Y, Li X, Deng HW, et al. Meta-analysis suggests that smoking is associated with an increased risk of early natural menopause. Menopause. 2012;19:126–32. doi: 10.1097/gme.0b013e318224f9ac.
    1. Harlow BL, Signorello LB. Factors associated with early menopause. Maturitas. 2000;35:3–9. doi: 10.1016/S0378-5122(00)00092-X.
    1. Parente RC, Faerstein E, Celeste RK, Werneck GL. The relationship between smoking and age at the menopause: a systematic review. Maturitas. 2008;61:287–98. doi: 10.1016/j.maturitas.2008.09.021.
    1. Yasui T, Hayashi K, Mizunuma H, Kubota T, Aso T, Matsumura Y, et al. Factors associated with premature ovarian failure, early menopause and earlier onset of menopause in Japanese women. Maturitas. 2012;72:249–55. doi: 10.1016/j.maturitas.2012.04.002.
    1. Fleming LE, Levis S, LeBlanc WG, Dietz NA, Arheart KL, Wilkinson JD, et al. Earlier age at menopause, work, and tobacco smoke exposure. Menopause. 2008;15:1103–8. doi: 10.1097/gme.0b013e3181706292.
    1. Tawfik H, Kline J, Jacobson J, Tehranifar P, Protacio A, Flom JD, et al. Life course exposure to smoke and early menopause and menopausal transition. Menopause. 2015;22:1076–83. doi: 10.1097/GME.0000000000000444.
    1. Chang SH, Kim CS, Lee KS, Kim H, Yim SV, Lim YJ, et al. Premenopausal factors influencing premature ovarian failure and early menopause. Maturitas. 2007;58:19–30. doi: 10.1016/j.maturitas.2007.04.001.
    1. Peck JD, Quaas AM, Craig LB, Soules MR, Klein NA, Hansen KR. Lifestyle factors associated with histologically derived human ovarian non-growing follicle count in reproductive age women. Hum Reprod. 2016;31:150–7. doi: 10.1093/humrep/dev271.
    1. Progetto Menopausa Italia Study Group Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy. BJOG. 2003;110:59–63. doi: 10.1046/j.1471-0528.2003.02129.x.
    1. Gregoraszczuk EL, Ptak A. Endocrine-disrupting chemicals: some actions of POPs on female reproduction. Int J Endocrinol. 2013;2013:828532.
    1. Kilic S, Yuksel B, Lortlar N, Sertyel S, Aksu T, Batioglu S. Environmental tobacco smoke exposure during intrauterine period promotes granulosa cell apoptosis: a prospective, randomized study. J Matern Fetal Neonatal Med. 2012;25:1904–8. doi: 10.3109/14767058.2012.678440.
    1. Gannon AM, Stampfli MR, Foster WG. Cigarette smoke exposure leads to follicle loss via an alternative ovarian cell death pathway in a mouse model. Toxicol Sci. 2012;125:274–84. doi: 10.1093/toxsci/kfr279.
    1. Jurisicova A, Taniuchi A, Li H, Shang Y, Antenos M, Detmar J, et al. Maternal exposure to polycyclic aromatic hydrocarbons diminishes murine ovarian reserve via induction of Harakiri. J Clin Invest. 2007;117:3971–8.
    1. Paixao LL, Gaspar-Reis RP, Gonzalez GP, Santos AS, Santana AC, Santos RM, et al. Cigarette smoke impairs granulosa cell proliferation and oocyte growth after exposure cessation in young Swiss mice: an experimental study. J Ovarian Res. 2012;5:25. doi: 10.1186/1757-2215-5-25.
    1. Caserta D, Bordi G, Di Segni N, D’Ambrosio A, Mallozzi M, Moscarini M. The influence of cigarette smoking on a population of infertile men and women. Arch Gynecol Obstet. 2013;287:813–8. doi: 10.1007/s00404-012-2643-5.
    1. Freour T, Masson D, Mirallie S, Jean M, Bach K, Dejoie T, et al. Active smoking compromises IVF outcome and affects ovarian reserve. Reprod Biomed Online. 2008;16:96–102. doi: 10.1016/S1472-6483(10)60561-5.
    1. Camlin NJ, Sobinoff AP, Sutherland JM, Beckett EL, Jarnicki AG, Vanders RL, et al. Maternal smoke exposure impairs the long-term fertility of female offspring in a murine model. Biol Reprod. 2016;94:39. doi: 10.1095/biolreprod.115.135848.
    1. Fraser A, McNally W, Sattar N, Anderson EL, Lashen H, Fleming R, et al. Prenatal exposures and anti-Mullerian hormone in female adolescents: the Avon Longitudinal Study of Parents and Children. Am J Epidemiol. 2013;178:1414–23. doi: 10.1093/aje/kwt137.
    1. Strohsnitter WC, Hatch EE, Hyer M, Troisi R, Kaufman RH, Robboy SJ, et al. The association between in utero cigarette smoke exposure and age at menopause. Am J Epidemiol. 2008;167:727–33. doi: 10.1093/aje/kwm351.
    1. Fowler PA, Childs AJ, Courant F, MacKenzie A, Rhind SM, Antignac JP, et al. In utero exposure to cigarette smoke dysregulates human fetal ovarian developmental signalling. Hum Reprod. 2014;29:1471–89. doi: 10.1093/humrep/deu117.
    1. Ernst A, Kristensen SL, Toft G, Thulstrup AM, Hakonsen LB, Olsen SF, et al. Maternal smoking during pregnancy and reproductive health of daughters: a follow-up study spanning two decades. Hum Reprod. 2012;27:3593–600. doi: 10.1093/humrep/des337.
    1. Lutterodt MC, Sorensen KP, Larsen KB, Skouby SO, Andersen CY, Byskov AG. The number of oogonia and somatic cells in the human female embryo and fetus in relation to whether or not exposed to maternal cigarette smoking. Hum Reprod. 2009;24:2558–66. doi: 10.1093/humrep/dep226.
    1. Butts SF, Sammel MD, Greer C, Rebbeck TR, Boorman DW, Freeman EW. Cigarettes, genetic background, and menopausal timing: the presence of single nucleotide polymorphisms in cytochrome P450 genes is associated with increased risk of natural menopause in European-American smokers. Menopause. 2014;21:694–701. doi: 10.1097/GME.0000000000000140.
    1. Lim J, Lawson GW, Nakamura BN, Ortiz L, Hur JA, Kavanagh TJ, et al. Glutathione-deficient mice have increased sensitivity to transplacental benzo[a]pyrene-induced premature ovarian failure and ovarian tumorigenesis. Cancer Res. 2013;73:908–17. doi: 10.1158/0008-5472.CAN-12-3636.
    1. Sirotkin AV, Harrath AH. Phytoestrogens and their effects. Eur J Pharmacol. 2014;741:230–6. doi: 10.1016/j.ejphar.2014.07.057.
    1. Wang W, Sun Y, Liu J, Li Y, Li H, Xiao S, et al. Soy isoflavones administered to rats from weaning until sexual maturity affect ovarian follicle development by inducing apoptosis. Food Chem Toxicol. 2014;72:51–60. doi: 10.1016/j.fct.2014.07.010.
    1. Jefferson WN, Padilla-Banks E, Newbold RR. Disruption of the female reproductive system by the phytoestrogen genistein. Reprod Toxicol. 2007;23:308–16. doi: 10.1016/j.reprotox.2006.11.012.
    1. Guillette LJ, Jr, Moore BC. Environmental contaminants, fertility, and multioocytic follicles: a lesson from wildlife? Semin Reprod Med. 2006;24:134–41. doi: 10.1055/s-2006-944419.
    1. Kim SH, Park MJ. Effects of phytoestrogen on sexual development. Korean J Pediatr. 2012;55:265–71. doi: 10.3345/kjp.2012.55.8.265.
    1. Patel S, Zhou C, Rattan S, Flaws JA. Effects of endocrine-disrupting chemicals on the ovary. Biol Reprod. 2015;93:20.
    1. Hombach-Klonisch S, Pocar P, Kietz S, Klonisch T. Molecular actions of polyhalogenated arylhydrocarbons (PAHs) in female reproduction. Curr Med Chem. 2005;12:599–616.
    1. Sharma R, Sharma M, Sharma R, Sharma V. The impact of incinerators on human health and environment. Rev Environ Health. 2013;28:67–72. doi: 10.1515/reveh-2012-0035.
    1. Sorg O. AhR signalling and dioxin toxicity. Toxicol Lett. 2014;230:225–33. doi: 10.1016/j.toxlet.2013.10.039.
    1. White SS, Birnbaum LS. An overview of the effects of dioxins and dioxin-like compounds on vertebrates, as documented in human and ecological epidemiology. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009;27:197–211. doi: 10.1080/10590500903310047.
    1. Shi Z, Valdez KE, Ting AY, Franczak A, Gum SL, Petroff BK. Ovarian endocrine disruption underlies premature reproductive senescence following environmentally relevant chronic exposure to the aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biol Reprod. 2007;76:198–202. doi: 10.1095/biolreprod.106.053991.
    1. Eskenazi B, Warner M, Marks AR, Samuels S, Gerthoux PM, Vercellini P, et al. Serum dioxin concentrations and age at menopause. Environ Health Perspect. 2005;113:858–62. doi: 10.1289/ehp.7820.
    1. Vorkamp K. An overlooked environmental issue? A review of the inadvertent formation of PCB-11 and other PCB congeners and their occurrence in consumer products and in the environment. Sci Total Environ. 2016;541:1463–76. doi: 10.1016/j.scitotenv.2015.10.019.
    1. Pocar P, Brevini TA, Fischer B, Gandolfi F. The impact of endocrine disruptors on oocyte competence. Reproduction. 2003;125:313–325. doi: 10.1530/rep.0.1250313.
    1. Shirota M, Mukai M, Sakurada Y, Doyama A, Inoue K, Haishima A, et al. Effects of vertically transferred 3,3′,4,4′,5-pentachlorobiphenyl (PCB-126) on the reproductive development of female rats. J Reprod Dev. 2006;52:751–61. doi: 10.1262/jrd.18062.
    1. Pocar P, Fiandanese N, Secchi C, Berrini A, Fischer B, Schmidt JS, et al. Effects of polychlorinated biphenyls in CD-1 mice: reproductive toxicity and intergenerational transmission. Toxicol Sci. 2012;126:213–26. doi: 10.1093/toxsci/kfr327.
    1. Grandjean P, Clapp R. Perfluorinated Alkyl Substances: Emerging Insights Into Health Risks. New Solut. 2015;25:147–63. doi: 10.1177/1048291115590506.
    1. Taylor KW, Hoffman K, Thayer KA, Daniels JL. Polyfluoroalkyl chemicals and menopause among women 20–65 years of age (NHANES) Environ Health Perspect. 2014;122:145–50.
    1. Knox SS, Jackson T, Javins B, Frisbee SJ, Shankar A, Ducatman AM. Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab. 2011;96:1747–53. doi: 10.1210/jc.2010-2401.
    1. Boekelheide K, Darney SP, Daston GP, David RM, Luderer U, Olshan AF, et al. NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of 2-bromopropane. Reprod Toxicol. 2004;18:189–217. doi: 10.1016/j.reprotox.2003.10.003.
    1. Kinney A, Kline J, Kelly A, Reuss ML, Levin B. Smoking, alcohol and caffeine in relation to ovarian age during the reproductive years. Hum Reprod. 2007;22:1175–85. doi: 10.1093/humrep/del496.
    1. Lefevre PL, Berger RG, Ernest SR, Gaertner DW, Rawn DF, Wade MG, et al. Exposure of female rats to an environmentally relevant mixture of brominated flame retardants targets the ovary,affecting folliculogenesis and steroidogenesis. Biol Reprod. 2016;94:9. doi: 10.1095/biolreprod.115.134452.
    1. Ogliari KS, Lichtenfels AJ, de Marchi MR, Ferreira AT, Dolhnikoff M, Saldiva PH. Intrauterine exposure to diesel exhaust diminishes adult ovarian reserve. Fertil Steril. 2013;99:1681–8. doi: 10.1016/j.fertnstert.2013.01.103.
    1. Nakamura N, Inselman AL, White GA, Chang CW, Trbojevich RA, Sephr E, et al. Effects of maternal and lactational exposure to 2-hydroxy-4-methoxybenzone on development and reproductive organs in male and female rat offspring. Birth Defects Res B Dev Reprod Toxicol. 2015;104:35–51. doi: 10.1002/bdrb.21137.
    1. Pelosi E, Simonsick E, Forabosco A, Garcia-Ortiz JE, Schlessinger D. Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause. Biol Reprod. 2015;92:130. doi: 10.1095/biolreprod.114.127381.
    1. Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, et al. EDC-2: the endocrine Society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36:E1–150. doi: 10.1210/er.2015-1010.
    1. Zheng W, Nagaraju G, Liu Z, Liu K. Functional roles of the phosphatidylinositol 3-kinases (PI3Ks) signaling in the mammalian ovary. Mol Cell Endocrinol. 2012;356:24–30. doi: 10.1016/j.mce.2011.05.027.
    1. Siroux V, Agier L, Slama R. The exposome concept: a challenge and a potential driver for environmental health research. Eur Respir Rev. 2016;25:124–9. doi: 10.1183/16000617.0034-2016.
    1. Rappaport SM. Genetic factors are not the major causes of chronic diseases. PLoS One. 2016;11:e0154387. doi: 10.1371/journal.pone.0154387.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit